Core Viewpoint - The recent trading activity of Yaojie Ankang-B (02617) has exhibited extreme volatility, characterized by a rapid price surge followed by a significant decline, indicating a potential manipulation of stock prices by major players in the market [1]. Group 1: Price Surge Phase - From September 5 to September 15, 2025, the stock experienced a staggering increase of 593.40% with a volatility of 620.72%, marked by a high turnover rate of 14.78% and a dominant bullish trend with 6 up days against 1 down day [2][3]. - The total trading volume during this period reached 44.58 million shares, with a total transaction value of 7.763 billion [3]. - Major funds aggressively bought shares, creating a "star stock" effect to attract attention and speculative trading, while also facilitating a redistribution of shares from weaker hands to stronger ones [4]. Group 2: Distribution Phase - From September 16 to October 15, 2025, the stock price plummeted from a high of 679.50 to a low of 111.00, reflecting a maximum decline of over 72% [7][8]. - The trading volume during this period was 59.19 million shares, with a total value of 13.0581 billion, and a predominance of bearish trading days (13 down days vs. 6 up days) [8]. - The selling pressure was primarily driven by the deep stock connect funds, which significantly reduced their holdings, while the Shanghai stock connect funds attempted to stabilize the price through selective buying [9]. Group 3: Short-term Rebound - A brief rebound occurred on October 16 and 17, 2025, with a two-day increase of 78.85% and a volatility of 98.50%, indicating a classic "dead cat bounce" pattern [10][11]. - The total trading volume for this rebound was 22.76 million shares, all of which were bullish, suggesting that new buying interest emerged from international short-term traders [10][12]. - The rebound was not supported by the original major holders, who instead viewed it as an opportunity to reduce their positions, indicating a lack of confidence in a sustained recovery [14].
从679元到112元，再回到224元：药捷安康-B（02617）是谁在“造神”？